USPTO serial 79059014
BIFICOL
Reviewed by CopyMark Law Group
Reg. 3676661Status 404
- Filing date
- Status date
- Registration date
- Sep 1, 2009
- Examiner
- TANNER, MICHAEL R
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BIFICOL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
JOHN P. MURTAUGH
JOHN P. MURTAUGH PEARNE & GORDON LLP1801 EAST 9TH STREET, SUITE 1200CLEVELAND, OH 44114-3108UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Microorganisms and cultures of micro-organisms in the nature of bacteria, bifidobacteria, yeast and fermented milk products, namely, cultures of microorganisms comprising bacteria, bifidobacteria, or yeast other than for medical or veterinary use, nutrients for use with yeast for industrial use, fermentation extracts and bacteria in the nature of bifidobacteria for use in food manufacture, namely, in food supplements manufacture; fermentation extracts and bacteria for use in food manufacture, namely, microorganisms and cultures of microorganisms, in particular probiotic lactic bacteria, probiotic bifidobacteria for administering to human beings and animal livestock species, not for medical or veterinary use; fermentation extracts and bacteria for use in food manufacture, namely, microorganisms and concentrated cultures of probiotic microorganisms in liquid, solid, dried and freeze-dried form for use in food manufacture, namely, in food supplements manufacture | SECTION 71 - CANCELLED | — |
| 005 | Bacterial and bacteriological preparations for medical or veterinary purposes, namely, microorganisms and cultures of microorganisms, in particular probiotic lactic bacteria or probiotic bifidobacteria for administering to human beings and to animal livestock species, for medical and veterinary use; bacterial and bacteriological preparations for medical or veterinary purposes, namely, microorganisms and cultures of microorganisms, in particular probiotic lactic bacteria or probiotic bifidobacteria capable of inducing a metabolic action able to affect cholesterol levels in blood; pharmaceutical preparations containing microorganisms and cultures of microorganisms, in particular probiotic lactic bacteria or probiotic bifidobacteria for treating diseases of the intestinal bacterial flora; pharmaceutical preparations containing microorganisms and cultures of microorganisms, in particular probiotic lactic bacteria or probiotic bifidobacteria for restoring the balance of the intestinal bacterial flora when changed in the course of treatment with antibiotics or chemotherapy; pharmaceutical preparations containing microorganisms and cultures of microorganisms, in particular probiotic lactic bacteria or probiotic bifidobacteria for treating acute and chronic gastro-intestinal diseases caused by a change in the intestinal bacterial flora; pharmaceutical preparations containing microorganisms and cultures of microorganisms, in particular probiotic lactic bacteria or probiotic bifidobacteria for treating intestinal dismicrobic syndromes, caused by diseases that cause changes in the bacterial flora, namely, diarrhea, gastroenteritis, non-specific enteritis, colitis, ulcerous colitis and Crohn's disease; pharmaceutical preparations in capsule, compress, solution, suspension, granule, dried granulate or freeze-dried granulate form for use in the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, for use in preventing intestinal inflammation in which inflammation is present on the intestinal wall, and for use in the treatment and prevention of antibiotic associated diarrhea; food supplements; food supplements for medical use containing microorganisms and cultures of microorganisms, in particular probiotic lactic bacteria or probiotic bifidobacteria for administering to human beings; dietary supplements; food supplements containing microorganisms and cultures of microorganisms, in particular probiotic lactic bacteria or probiotic bifidobacteria for administering to human beings, not for medical use; symbiotic supplements containing microorganisms or cultures of microorganisms, in particular probiotic lactic bacteria, probiotic bifidobacteria and prebiotic fibres, namely, symbiotic dietary or nutritional supplements containing microorganisms or cultures of microorganisms, in particular probiotic lactic bacteria, probiotic bifidobacteria and prebiotic fibres | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PROBIOTICAL S.P.A.
- Other trademarks owned by PROBIOTICAL S.P.A.
- Other trademarks owned by PROBIOTICAL S.P.A.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named BIFICOL
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 9, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 15, 2019 | DENC | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED | — |
| Feb 15, 2019 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Apr 21, 2017 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 17, 2017 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Feb 3, 2017 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Feb 3, 2017 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Dec 8, 2016 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Apr 8, 2016 | C71T | CANCELLED SECTION 71 | — |
| Feb 26, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 27, 2014 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 28, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 25, 2011 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 6, 2010 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jan 6, 2010 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 1, 2009 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 1, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 16, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 27, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| May 12, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 12, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 22, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 22, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 22, 2009 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 21, 2009 | ALIE | ASSIGNED TO LIE | — |
| Apr 21, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 20, 2009 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 20, 2009 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 20, 2009 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 7, 2009 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 6, 2008 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 20, 2008 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 5, 2008 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 5, 2008 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 5, 2008 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 4, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 30, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 21, 2008 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 17, 2008 | NWAP | NEW APPLICATION ENTERED | — |
| Oct 16, 2008 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |